Atrinsic, Inc. is a biotechnology company focusing on the discovery and development of naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. Its products include PT00114 and PT00121, which are peptide-based formulations for the treatment of anxiety and depression disorders. Atrinsic, Inc. was incorporated in 2004 and is based in New York, New York.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• No BuyIns.Net Alerts Available for ATRN